OGT Launches New Panel for Myeloid Cancer
OGT launched a new next-generation sequencing (NGS) tool designed to identify key fusion genes associated with acute myeloid leukemia (AML).
Read MorePosted by Andy Lundin | Apr 30, 2024 | Leukemia, Molecular Diagnostics |
OGT launched a new next-generation sequencing (NGS) tool designed to identify key fusion genes associated with acute myeloid leukemia (AML).
Read MorePosted by Andy Lundin | Apr 17, 2024 | Cervical (HPV), Sequencing Systems, Urinalysis & Toxicology |
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MorePosted by Andy Lundin | Mar 12, 2024 | Flow Cytometry Instruments |
The DxFLEX Flow Cytometer is designed to make multicolor flow cytometry less complex by harnessing APD detector technology.
Read MorePosted by Andy Lundin | Jan 30, 2024 | Leukemia |
A pilot study proposes a promising clinically applicable genomic assay for the diagnosis of a heterogeneous pediatric leukemia.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Leukemia |
An AI-based solution may help predict various genetic features based on microscopic images of bone marrow smears to improve AML diagnosis.
Read More